This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Fluffy Unicorn (2017-08-03)
- Starting date:
- August 3, 2017
- Posting date:
- August 9, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Natural health products
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-64192
Reason
Product sold without market authorization (NPN) in Canada. Product contains undeclared synephrine that in combination with caffeine may pose a risk to health.
Depth of distribution
Retailers
Affected products
Fluffy Unicorn
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Powder
Strength
500mg (4-Amynobutyl) guanidinium sulphate
200mg 1,3,7-Trimethylxanthine
2300mg 2-aminoethanesulfonic acid
5000mg Citrulline malate
1000mg Glycine, N- (aminoiminoMethyl) -N-Methyl-, monohydrochloride
Lot or serial number
All Lots
Companies
- Recalling Firm
-
Distribution Limitless
8705 Rue Magloire-Lavallée
Mirabel
J7N OX9
Quebec
CANADA
- Marketing Authorization Holder
-
Not Applicable